The use of drugs in patients who have undergone bariatric surgery
- PMID: 24872717
- PMCID: PMC4026560
- DOI: 10.2147/IJGM.S55332
The use of drugs in patients who have undergone bariatric surgery
Abstract
According to the World Health Organization, obesity has become an epidemic in the 21st century affecting around 300 million people of all ages worldwide. Clinical treatment modalities for this disease are limited and ineffective when it comes to morbidly obese patients (body mass index - the weight in kilograms divided by height in meters squared - surpasses 40 kg/m(2)). Therefore, the alternative, surgical treatment, is the best option for these patients, namely gastric restrictive procedures or an intestinal bypass culminating in a malabsorptive syndrome. In the past 20 years, there has been a 70% increase in the number of bariatric procedures all over the world. The main pharmacokinetic consequence observed in the postoperative period of these individuals is a higher or lower absorption of orally administered drugs.
Keywords: anatomophysiological alterations; obesity; pharmacokinetic.
References
-
- Marcelino LF, Patrício ZM. The complexity of obesity and life after bariatric surgery: a public health issue. Cien Saude Colet. 2011;16(12):4767–4776. Portuguese. - PubMed
-
- Sanches GD, Gazoni FM, Konishi RK, et al. Intensive care of postoperative patients in bariatric surgery. Rev Bras Ter Intensiva. 2007;19(2):205–209. Portuguese. - PubMed
-
- Zilberstein B, Neto MG, Ramos AC. The role of surgery in the treatment of obesity. Rev Bras Med. 2002;59(4):258–264. Portuguese.
-
- Csendes A1, Burdiles P, Papapietro K, Burgos AM. Review of the results of medical and surgical treatment of morbid obesity. Rev Med Chil. 2009;137(4):559–566. Spanish. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
